Polimorfisme Gen Cyclooxygenase-2 dan Prevalensi Hipertensi Masyarakat Indonesia

Yuda Nabella Prameswari(1),


(1) Universitas Sultan Ageng Tirtayasa
(*) Corresponding Author

Abstract


Hypertension is a major risk factor for cardiovascular diseases, leading to serious health complications. Genetic polymorphisms in the COX-2 gene, especially the rs689466 variant, are associated with increased cardiovascular risk, but its link to hypertension in the Indonesian population remains limited. This study investigates the relationship between COX-2 rs689466 polymorphism and hypertension in Indonesia, using a cross-sectional design with 200 samples (100 hypertensive patients and 100 healthy individuals). DNA was isolated from whole blood using the salting-out method, and the COX-2 rs689466 polymorphism was analyzed by PCR-RFLP. Statistical analysis was performed using the Chi-square and Mann-Whitney tests. The results showed a significant association between the COX-2 rs689466 polymorphism and hypertension (p<0.001), with the AA genotype carrying a higher risk (p<0.001, OR=8.609) compared to individuals with the GG or AG genotypes. Smoking exacerbated this association, with smokers being more likely to carry the AA genotype and have an increased risk of hypertension (p<0.001, OR=6.091). This study highlights the role of COX-2 rs689466, particularly the AA genotype, in increasing hypertension risk in Indonesia, with smoking further worsening vascular inflammation and resistance, contributing to hypertension development.

Keywords - Cyclooxygenase-2 (COX-2), Hypertension, Polymorphism, Smoking, Rs689466.

Full Text:

PDF

References


D. Aune, W. Huang, J. Nie, Y. Wang "Hypertension and the Risk of All‐Cause and Cause‐Specific Mortality: An Outcome‐Wide Association Study of 67 Causes of Death in the National Health Interview Survey," Biomed. Res. Int., vol. 2021, no. 1, Jan. 2021. [Online]. Available: https://onlinelibrary.wiley.com/doi/10.1155/2021/9376134.

World Health Organization. Hypertension Profile in the World. Geneva: WHO, 2023, pp. 1–194.

Badan Kebijakan Pembangunan Kesehatan. Prevalensi, Dampak, serta Upaya Pengendalian Hipertensi & Diabetes di Indonesia. Jakarta: Kementerian Kesehatan Republik Indonesia, 2023, pp. 1–2. [Online]. Available: https://drive.google.com/file/d/1RGiLjySxNy4gvJLWG1gPTXs7QQRnkS--/view.

World Health Organization. WHO Hypertension Guidelines. Geneva: WHO, 2024.

World Health Organization Regional Office for South-East Asia, Background paper for the regional technical consultation on: Monitoring the health-related Sustainable Development Goals (SDGs). New Delhi, India:WHO-SEARO, Feb. 2017, pp. 1-10.

G. L. Bakris, M. J. Shan and L. J. Laffin. Hypertension. Amsterdam, Netherlands: Elsevier, 2024. [Online]. Available: https://linkinghub.elsevier.com/retrieve/pii/C20210013961.

P. K. Whelton, R. M. Carey, G. Mancia, R. Kreutz, J. D. Bundy, and B. Williams, "Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines," J. Am. Coll Cardiol., vol. 80, no. 12, pp. 1192-201, Sep. 2022. [Online]. Available: https://linkinghub.elsevier.com/retrieve/pii/S0735109722055930.

J. Ma, and X. Chen, "Advances in pathogenesis and treatment of essential hypertension," Front. Cardiovasc. Med., vol. 9, Oct. 2022. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1003852/full.

Y. Wang, Q. Zhou, W. H. Gao, Y. Yan, C. Chu, C. Chen, et al., "Association of plasma cyclooxygenase-2 levels and genetic polymorphisms with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adults," J. Hypertens., vol. 38, no. 9, pp. 1745-1754, Sep. 2020. [Online]. Available: https://journals.lww.com/10.1097/HJH.0000000000002473.

K. N. Pandey. "Genetic and epigenetic mechanisms regulating blood pressure and kidney dysfunction," Hypertension, vol. 81, no. 7, pp. 1424-1437, Jul. 2024. [Online]. Available: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.124.22072.

T. Green, A. A. Gonzalez, K. D. Mitchell, and L. G. Navar, "The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function," Curr. Opin. Nephrol. Hypertens., vol. 21, no. 1, pp. 7-14, Jan. 2012. [Online]. Available: https://journals.lww.com/00041552-201201000-00003.

R. Sun, R. Tanino, X. Tong, M. Isomura, L. J. Chen, T. Hotta, et al., "The association between cyclooxygenase-2 –1195g/a (rs689466) gene polymorphism and the clinicopathology of lung cancer in the Japanese population: A case-controlled study," Front. Genet., vol. 13, Apr. 2022. [Online]. Available: https://www.frontiersin.org/articles/10.3389/fgene.2022.796444/full.

J. Wu, X. Han, D. Sun, J. Zhang, J. Li, G. Qin, et al., "Age-specific association of stage of hypertension at diagnosis with cardiovascular and all-cause mortality among elderly patients with hypertension: A cohort study," BMC Cardiovasc. Disord., vol. 23, no. 1, pp. 270, May. 2023 [Online]. Available: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-023-03250-7.

J. M. Nolde, T. Beaney, R. Carnagarin, G. S. Stergiou, N. R. Poulter, A. E. Schutte, et al., "Age-related blood pressure gradients are associated with blood pressure control and global population outcomes," Hypertension, vol. 81, no. 10, pp. 2091-2100, Oct. 2024. [Online]. Available: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.124.23406.

The China PEACE Collaborative Group, "Association of age and blood pressure among 3.3 million adults: insights from China PEACE million persons project," J Hypertens., vol. 39, no. 6, pp. 1143-1154, Jun. 2021. [Online]. Available: https://journals.lww.com/10.1097/HJH.0000000000002793.

C. Wang, Y. Yuan, M. Zheng, A. Pan, M. Wang, M. Zhao, et al., "Association of age of onset of hypertension with cardiovascular diseases and mortality," J. Am. Coll. Cardiol., vol. 75, no. 23, pp. 2921-2930, Jun. 2020. [Online]. Available: https://linkinghub.elsevier.com/retrieve/pii/S0735109720350221.

P. J. Connelly, G. Currie, C. Delles, "Sex differences in the prevalence, outcomes and management of hypertension," Curr Hypertens Rep., vol. 24, no. 6, pp. 185-192, Jun. 2022. [Online]. Available: https://link.springer.com/10.1007/s11906-022-01183-8.

A. B. Lauber, M. L. Muritano, "Estrogens: Two nuclear receptors, multiple possibilities," Mol. Cell. Endocrinol., vol. 554, pp. 111710, Aug. 2022. [Online]. Available: https://linkinghub.elsevier.com/retrieve/pii/S0303720722001587 .

D. Strategy, Tobacco Control: What the Executive Branch. United Nations, UNDP, pp. 4–5, 2025.

H. Andriani, R. I. Kosasih, S. Putri, and H. W. Kuo, "Effects of changes in smoking status on blood pressure among adult males and females in Indonesia: a 15-year population-based cohort study," BMJ Open [Internet]. vol. 10, no. 4, p. e038021, Apr. 30, 2020. [Online]. Available: https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2020-038021.

M. Jareebi, "The association between smoking behavior and the risk of hypertension: review of the observational and genetic evidence," J. Multidiscip Healthc. [Internet]. vol. 17, pp. 3265-3281, Jul. 2024. [Online]. Available: https://www.dovepress.com/the-association-between-smoking-behavior-and-the-risk-of-hypertension--peer-reviewed-fulltext-article-JMDH.

L. Zhao, J. Fang, M. Zhou, J. Zhou, L. Yu, N. Chen, et al., "Interaction between COX-1 and COX-2 increases susceptibility to ischemic stroke in a Chinese population," BMC Neurol. [Internet]. vol. 19, no. 1, p. 291, Dec. 2019. [Online]. Available: https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-019-1505-1.

A. Kulesza, L. Paczek, and A. Burdzinska, "The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells,"Biomedicines [Internet]. vol. 11, no. 2, p. 445, Feb. 2023. [Online]. Available: https://www.mdpi.com/2227-9059/11/2/445.

S. Khan, K. L. Andrews, and J. P. F. Chin-Dusting, "Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?" Int. J. Mol. Sci. [Internet]. vol. 20, no. 17, p. 4262, Aug. 2019. [Online]. Available: https://www.mdpi.com/1422-0067/20/17/4262.

S. Kotlyarov, "The Role of Smoking in the Mechanisms of Development of Chronic Obstructive Pulmonary Disease and Atherosclerosis," Int. J. Mol. Sci. [Internet]. vol. 24, no. 10, p. 8725, May. 2023. [Online]. Available: https://www.mdpi.com/1422-0067/24/10/8725.

M. Abohelwa, J. Kopel, S. Shurmur, M. M. Ansari, Y. Awasthi, S. Awasthi, "The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review," J. Vasc. Dis. [Internet]. vol. 2, no. 1, pp. 122-164, Feb. 2023. [Online]. Available: https://www.mdpi.com/2813-2475/2/1/10.

Y. N. Prameswari and D. A. Suryandari, "Correlation Epidermal Growth Factor Receptor Mutation with Non-small Cell Lung Cancer in Passive Smokers: A Review", Bioscmed, vol. 6, no. 4, pp. 1624-1635, Feb. 2022. https://doi.org/10.37275/bsm.v6i4.484.

T. Ojangba, S. Boamah, Y. Miao, X. Guo, Y. Fen, C. Agboyibor, J. Yuan, and W. Dong, "Comprehensive effects of lifestyle reform, adherence, and related factors on hypertension control: A review," Journal of Clinical Hypertension (Greenwich, Conn.), vol. 25, no. 6, pp. 509-520, 2023. doi: 10.1111/jch.14653.




DOI: http://dx.doi.org/10.36722/sst.v10i3.4246

Refbacks

  • There are currently no refbacks.


LP2M (Lembaga Penelitian dan Pengembangan Masyarakat)

Universitas AL-AZHAR INDONESIA, Lt.2 Ruang 207

Kompleks Masjid Agung Al Azhar

Jl. Sisingamangaraja, Kebayoran Baru

Jakarta Selatan 12110

Visitor

 This work is licensed under CC BY 4.0